Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

Eun-Kee Song

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

Eun-Kee Song

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Journal of Clinical Oncology
State	Published - 2015.11.20

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{3c964445926b4bd79960c9297b18530d,

title = "Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer",

author = "Eun-Kee Song",

year = "2015",

month = nov,

day = "20",

language = "Korean",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

}

TY - JOUR

T1 - Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

AU - Song, Eun-Kee

PY - 2015/11/20

Y1 - 2015/11/20

M3 - Journal article

SN - 0732-183X

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -